The stock's surge seems unsustainable with weak revenue and ...
The stock's surge seems unsustainable with weak revenue and growth prospects. Low Price-to-Sales ratio may drop if no revenue boost occurs, risking further disappointment.
Guangdong VTR Bio-Tech Co., Ltd. (SZSE:300381) Held Back By Insufficient Growth Even After Shares Climb 41%
免責聲明:以上信息不代表Moomoo Technologies Inc.("MTI")的任何立場,不構成與MTI及其關聯公司的任何投資建議。
更多信息
評論
登錄發表評論